| Code | CSB-MP3536MOV |
| Abbreviation | Recombinant Cynomolgus monkey DLL3 protein, partial (Active) |
| MSDS | |
| Size | $190 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
DLL3 has emerged as a compelling therapeutic target in neuroendocrine tumors, making well-characterized cynomolgus monkey orthologs essential for preclinical antibody cross-reactivity screening and pharmacokinetic studies. This recombinant Macaca fascicularis DLL3 (residues 27–490) is produced in mammalian cells with a C-terminal 6xHis tag, preserving native-like glycosylation critical for accurate binding assessments. Functional ELISA validation demonstrates robust activity, with immobilized DLL3 at 2 μg/mL binding an anti-DLL3 recombinant antibody at an EC50 of 1.625–2.702 ng/mL, confirming suitability as a reliable positive control in antibody screening, epitope binning, and species cross-reactivity evaluation. Purity exceeding 85% by SDS-PAGE combined with endotoxin levels below 1.0 EU/μg satisfies the criteria typically required for sensitive cell-based Notch signaling assays and SPR-based affinity measurements where low background interference is essential.
There are currently no reviews for this product.